Neutze J, Van Nostrand D, Major W
Clin Nucl Med. 1985 Nov;10(11):777-9. doi: 10.1097/00003072-198511000-00005.
Radionuclide peritoneoscintigraphy has been used prior to chromic phosphate P-32 (P-32CP) intraperitoneal therapy to assure proper placement of the catheter in the peritoneal cavity, to exclude loculation, and to predict inadequate distribution of P-32CP. This is a case report of the detection of a peritoneal catheter improperly placed into the bowel lumen by pretherapy radionuclide peritoneoscintigraphy, and this case demonstrates the distinguishing characteristics of the radiocolloid distribution secondary to an intraluminal injection relative to an intraperitoneal injection.
在进行磷酸铬P-32（P-32CP）腹腔内治疗之前，已采用放射性核素腹膜闪烁造影术来确保导管在腹腔内的正确放置，排除肠粘连，并预测P-32CP分布不充分的情况。本文报告了1例通过治疗前放射性核素腹膜闪烁造影术检测到腹膜导管误置于肠腔内的病例，该病例展示了肠腔内注射相对于腹腔内注射所致放射性胶体分布的显著特征。
